Difference between revisions of "WSI21-216-Case-1"

From MGH Learn Pathology
(Edited automatically from page WSI21-216.)
(Automatic edit to upgrade to new templates)
Line 1: Line 1:
{{dziCase
+
{{ServiceRequestCase
|qc=yes
+
|identifier=WSI21-216-Case-1
|qcuser=Aja51
+
|intent=order
|qctime=Dec 07, 2021 19:29:21
+
|category=409073007
|order_date=December 02, 2021 08:55:33 PM
+
|priority=routine
|user=Vn048
+
|orderDetail=case
|dziorder=WSI21-216
+
|locationCode=learn
|case_id=1
+
|basedOn=WSI21-216
|publish_timestamp=12/08/2021 13:00:00
+
|code=outs
|clinical_hx=65 yo woman with leukocytosis (WBC 20.42; HGB 13.1; HCT: 39.8%; MCV: 85.4; PLT: 348) and occasional circulating blasts.
+
|supportingInfo=Post-polycythemia vera myelofibrosis
|case_diagnosis=Post-polycythemia vera myelofibrosis
+
|reasonCode=65 yo woman with leukocytosis (WBC 20.42; HGB 13.1; HCT: 39.8%; MCV: 85.4; PLT: 348) and occasional circulating blasts.
 +
|subject=MGH
 +
|performer=Vn048
 +
|authoredOn=December 02, 2021 08:55:33 PM
 +
|requester=Vn048
 +
|sequence=1
 
}}
 
}}
{{wsiSlide
+
{{Media
|order_date=December 02, 2021 08:55:33 PM
+
|basedOn=WSI21-216-Case-1
|user=Vn048
+
|type=image
|source_filename=Z0FBQUFBQmhxVE9BSmxhUG1oalhTZTZ4SE42X3pFMnQwNVRWS2hzYW5HN2UtMlVxek5La0EzdWlvTlpwUV8zc2N1dHhzM3ZDbWRTRzBXWjg5ZzN6VlA2bGtFTWN3S2JiUk9POXI3NEEyUG5FUHpfQnliRFJaeDQ9
+
|view=show
|slide_stain=H&E
+
|partOf=WSI21-216
|slide_anatomy=Show
+
|frames=1
 +
|reasonCode=H&E
 +
|identifier=WSI21-216-Case-1_1
 +
|createdDateTime=December 02, 2021 08:55:33 PM
 +
|operator=Vn048
 +
|subject=Z0FBQUFBQmhxVE9BSmxhUG1oalhTZTZ4SE42X3pFMnQwNVRWS2hzYW5HN2UtMlVxek5La0EzdWlvTlpwUV8zc2N1dHhzM3ZDbWRTRzBXWjg5ZzN6VlA2bGtFTWN3S2JiUk9POXI3NEEyUG5FUHpfQnliRFJaeDQ9
 +
|modality=mrxs
 
}}
 
}}
{{wsiSlide
+
{{Media
|order_date=December 02, 2021 08:55:33 PM
+
|basedOn=WSI21-216-Case-1
|user=Vn048
+
|type=image
|source_filename=Z0FBQUFBQmhxVE9NWkZqUkxUZ1pZTHRrVUd6M0JGU0NENm44enEycWVIZlRidG15RkxkVXozb0FlTzJxOVAyaG9QejRPcTRaS2hPS2hOV2FhYl9jdHFtRDd6aWxKZXhQWnBtQmxpaU5MZmF1QWlub3FxamVneTg9
+
|view=show
|slide_stain=Other
+
|partOf=WSI21-216
|slide_anatomy=Show
+
|frames=2
 +
|reasonCode=Other
 +
|identifier=WSI21-216-Case-1_2
 +
|createdDateTime=December 02, 2021 08:55:33 PM
 +
|operator=Vn048
 +
|subject=Z0FBQUFBQmhxVE9NWkZqUkxUZ1pZTHRrVUd6M0JGU0NENm44enEycWVIZlRidG15RkxkVXozb0FlTzJxOVAyaG9QejRPcTRaS2hPS2hOV2FhYl9jdHFtRDd6aWxKZXhQWnBtQmxpaU5MZmF1QWlub3FxamVneTg9
 +
|modality=mrxs
 
}}
 
}}
{{wsiSlide
+
{{Media
|order_date=December 02, 2021 08:55:33 PM
+
|basedOn=WSI21-216-Case-1
|user=Vn048
+
|type=image
|source_filename=Z0FBQUFBQmhxVE9rMzM5aFd0dVd5MUJGcnN2M3duVUhxeDF6NzRHa1g4MFR0VWp0S2poWGN0T2cyNEpFaW1GMnJ2aUJQRHlqQ1Bzbng4YzdVUFU3aWN3NXdVVldBYkJmWWc9PQ
+
|view=show
|slide_stain=CD34
+
|partOf=WSI21-216
|slide_anatomy=Show
+
|frames=3
 +
|reasonCode=CD34
 +
|identifier=WSI21-216-Case-1_3
 +
|createdDateTime=December 02, 2021 08:55:33 PM
 +
|operator=Vn048
 +
|subject=Z0FBQUFBQmhxVE9rMzM5aFd0dVd5MUJGcnN2M3duVUhxeDF6NzRHa1g4MFR0VWp0S2poWGN0T2cyNEpFaW1GMnJ2aUJQRHlqQ1Bzbng4YzdVUFU3aWN3NXdVVldBYkJmWWc9PQ
 +
|modality=mrxs
 
}}
 
}}
{{wsiSlide
+
{{Media
|order_date=December 02, 2021 08:55:33 PM
+
|basedOn=WSI21-216-Case-1
|user=Vn048
+
|type=image
|source_filename=Z0FBQUFBQmhxVFFVbi1lTDgxaDVrTW54a3lhQUNJZGZDS2VQbGpNbGlkb1RLQUE5V3k1cFpFSEhNUEJ1SV9sY0t1eXFUSG43NEJVVzJqbzZYV0pkQjR5SVBURG4yWFhMd3c9PQ
+
|view=show
|slide_stain=Other
+
|partOf=WSI21-216
|slide_anatomy=Show
+
|frames=4
 +
|reasonCode=Other
 +
|identifier=WSI21-216-Case-1_4
 +
|createdDateTime=December 02, 2021 08:55:33 PM
 +
|operator=Vn048
 +
|subject=Z0FBQUFBQmhxVFFVbi1lTDgxaDVrTW54a3lhQUNJZGZDS2VQbGpNbGlkb1RLQUE5V3k1cFpFSEhNUEJ1SV9sY0t1eXFUSG43NEJVVzJqbzZYV0pkQjR5SVBURG4yWFhMd3c9PQ
 +
|modality=mrxs
 
}}
 
}}

Revision as of 12:11, March 9, 2022

WSI21-216-Case-1
65 yo woman with leukocytosis (WBC 20.42; HGB 13.1; HCT: 39.8%; MCV: 85.4; PLT: 348) and occasional circulating blasts.
Post-polycythemia vera myelofibrosis
December 8, 2021 12:00:00 AM